Lyn Williamson

Lyn Williamson has a strong background in quality assurance and compliance. They have held various roles at different companies, with their most recent position being Director of Quality Assurance, GCP at Travere Therapeutics since 2021. In this role, they have developed and implemented quality programs, provided guidance on GCP issues, and monitored and escalated risks and non-compliance situations. Prior to this, they worked at PPD as a Director of Global Quality & Compliance and held various other positions in quality assurance and auditing. Before their time at PPD, they worked at SCIREX Corporation as a Quality Assurance Auditor, where they conducted GCP audits and ensured compliance with regulations and internal SOPs. Overall, Lyn Williamson has extensive experience in quality assurance and compliance within the clinical research industry.

Lyn Williamson received a Bachelor of Arts degree from Texas State University. In 2003, they obtained a certification as a Certified Quality Auditor from the American Society for Quality (ASQ).